More evidence on benefits of high blood pressure drugs in diabetic eye disease

More evidence on benefits of high blood pressure drugs in diabetic eye disease
The largest study to date of proteins in the retina, above, indicate that high blood pressure drugs may be useful in preventing diabetic eye disease. Credit: Wikimedia Commons, Danny Hope

Scientists in Massachusetts are reporting new evidence that certain high blood pressure drugs may be useful in preventing and treating diabetic retinopathy, the leading cause of vision loss in people with diabetes. The study, the largest to date on proteins in the retina, could lead to new ways to prevent or treat the sight-threatening disease, they say. The findings are in ACS' Journal of Proteome Research.

Edward Feener and colleagues point out that diabetic retinopathy is a common complication of diabetes, which affects millions of people worldwide. It involves damage to in the , the light sensitive tissue in the back of the eye. Previous studies suggested that drugs used to treat , including ACE inhibitors and angiotensin receptor blockers (ARBs), may help prevent the condition.

The scientists analyzed proteins from the retinas laboratory mice with normal blood pressure and diabetes and compared them to those of non-diabetic mice. They identified 65 abnormal proteins in the diabetic mice out of more than 1,700 proteins in the study. Treatment with the ARB medication, candesartan, prevented the abnormal changes in more than 70 percent of the proteins.


Explore further

Identifying abnormal protein levels in diabetic retinopathy

More information: "Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes", pubs.acs.org/doi/full/10.1021/pr9006415
Citation: More evidence on benefits of high blood pressure drugs in diabetic eye disease (2010, January 6) retrieved 8 April 2020 from https://medicalxpress.com/news/2010-01-evidence-benefits-high-blood-pressure.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments